Pharmaceutical Products - Medicines With The Active Ingredient Flecainide (Atc: C01bc04). The Subject Of This Publication Is The Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V On Medicines With The Active Ingredient Flecainide (Atc: C01bc04) As Part Of A So-Called “Open-House Model”. Under The Specification Of Uniform Contract Conditions As Well As A Uniform Access Procedure Will Be Available To All Suitable And Interested Parties Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Conclusion Or Entry Into A Discount Agreement In Accordance With Section 130 A Paragraph 8 Sgb V To The Aforementioned Active Ingredients Or Medicines Are Offered. Interested Pharmaceutical Companies You Can Send The Participation Documents And The Relevant Address To The Contact Address Mentioned Request Contract. The Prerequisite For Concluding A Contract Is That The Interested Party Is Interested Pharmaceutical Companies Completed The Requested Participation Documents Completely And Signed.
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 73796563
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.
